Novartis loses initial bid to block generic of best-selling heart drug
Novartis failed to persuade a federal court to bar generics maker MSN Pharmaceuticals from marketing its own version of Entresto, Novartis’ favoured drug, according to a court ruling on Monday.
ENTRADAS POPULARES
Putin may discuss Ukraine peace deal with Trump
noviembre 22, 2024
Spain’s vice-president Ribera blames floods on climate change
noviembre 22, 2024
Storm lashes northwestern US, killing two people
noviembre 22, 2024
Iceland volcano erupts for tenth time in three years
noviembre 22, 2024
TRANSMISIÓN EN VIVO